GlassScriptPhysician profile
Suhas D Mantri
NPI 1659452985
$8,005.43
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,919 · 2020: $381 · 2021: $1,409 · 2022: $2,765 · 2023: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $3,418.64 | 2020-2023 | Axonics |
| Caldera Medical, INC | $2,619.80 | 2019-2023 | Desara |
| Abbvie INC. | $302.64 | 2019-2023 | |
| Aspira Women'S Health INC | $280.23 | 2021-2023 | Ova1 |
| Boston Scientific Corporation | $271.95 | 2019-2022 | |
| Tela Bio, INC. | $161.73 | 2020 | |
| Pfizer INC. | $105.98 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $103.84 | 2023 | |
| Astellas Pharma US INC | $98.86 | 2023 | Veozah, Myrbetriq |
| Gynesonics, INC. | $95.20 | 2022 | |
| Northgate Technologies, INC. | $54.69 | 2022-2023 | Smoke Removel - Nebulae |
| Monaghan Medical Corporation | $52.89 | 2023 | Aerochamber, Aeroeclipse |
| Currax Pharmaceuticals LLC | $38.79 | 2019-2022 | |
| Allergan, INC. | $36.84 | 2020-2022 | |
| Agile Therapeutics, INC. | $33.80 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $32.60 | 2020-2021 | |
| Vivus LLC | $29.98 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $29.80 | 2019 | |
| Novo Nordisk INC | $27.69 | 2019-2020 | |
| Lupin INC. | $26.04 | 2019 | |
| Millicent US INC | $23.52 | 2020 | |
| Exeltis, USA INC. | $21.10 | 2023 | Slynd |
| Baxter Healthcare | $19.36 | 2023 | Adept |
| Myovant Sciences INC. | $18.80 | 2021 | |
| Lsi Solutions INC | $16.19 | 2019 | |
| Therapeuticsmd, INC. | $15.02 | 2019 | |
| Minerva Surgical, INC | $14.76 | 2021 | |
| Becton, Dickinson and Company | $13.82 | 2022 | |
| Bausch Health US, LLC | $13.40 | 2019 | |
| Coloplast Corp | $12.80 | 2019 | |
| Channel Medsystems, INC. | $9.26 | 2023 | |
| Organon LLC | $5.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suhas Mantri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.